Noureddin, MazenChan, Jean L.Barradas, KatherineDimick-Santos, LaraSchabel, ElmerOmokaro, Stephanie O.Anania, Frank A.Myers, Robert P.Miller, VeronicaSanyal, Arun J.Chalasani, Naga2020-06-252020-06-252020Noureddin, M., Chan, J. L., Barradas, K., Dimick-Santos, L., Schabel, E., Omokaro, S. O., Anania, F. A., Myers, R. P., Miller, V., Sanyal, A. J., & Chalasani, N. (2020). Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum. Gastroenterology. https://doi.org/10.1053/j.gastro.2020.04.039https://hdl.handle.net/1805/23103enPublisher Policynonalcoholic fatty liver diseaseNASH cirrhosisnonalcoholic steatohepatitisAttribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver ForumArticle